ETHYL 4-(TERT-BUTOXYCARBONYLAMINO)BENZOATE, 95.0%, 1g

5-Fluoro-3-(piperidin-4-yl)-1H-indole, 95.0%, 1g

ETHYL 2-AMINO-5,5-DIMETHYL-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLATE, 95%, 1g

2-Bromo-5-methoxybenzoic acid, 98.0%, 500g

1,3-Diacetylbenzene, 95.0%, 25g

GC-Kapillarsäule ROTI®Cap-35 MS, L 60 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

Aminoacetaldehyde dimethyl acetal, 99.0%, 25g

4H-Chromen-4-one, 95.0%, 1g

Vesatolimod, 99.90%, 10mg

3-CYCLOPROPYL-3-FLUOROAZETIDINE HCL, 95.0%, 250mg

1-(2-Chloro-6-fluorophenyl)ethanamine hydrochloride, 97.0%, 1g

Piperidin-1-yl-acetic acid, 95.0%, 100mg

3-Ethyl 5-(4-nitrobenzyl) 6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxylate, 98%, 100mg